Centene Corporation achieved a remarkable financial performance in the second quarter of 2026, reporting a profit of $1.1 billion. This reflected a substantial recovery from a reported loss of $253 million during the same period in 2025, making it the company's first quarterly gain after a previous downturn.
The managed care giant's revenue surged to $53.6 billion for the quarter, showcasing a 10% increase year over year. Such positive results enabled Centene to enhance its earnings outlook for 2026, a move that was well-received by analysts including TD Cowen's Ryan Langston, who described it as a significant achievement. CFO Drew Asher characterized the results as "fantastic" during a call with investors, marking the second time this year the company has revised its guidance upward following better-than-expected results.
With the improved financial performance, Centene has adjusted its projected adjusted earnings per share to exceed $4.80 for 2026, an increase from the previous estimate of $3.40. While this anticipated figure reflects a recovery, it remains lower than the $7.17 and $6.68 realized in 2024 and 2023, respectively. The enhancement of earnings guidance comes on the heels of a more effectively controlled medical cost environment set against a backdrop of elevated spending in previous years.
The Affordable Care Act (ACA) exchanges emerged as a pivotal factor in Centene's recent success, marking a turnaround for a segment that had previously hindered the company's earnings. Enrollment in ACA plans saw a decline of nearly 2.4 million people year over year, leaving around 3.5 million enrollees. However, the remaining members proved to be considerably more profitable and contributed positively to Centene's bottom line as premium adjustments were implemented to accommodate rising medical care costs.
The adjustment in premium rates was essential, especially given the broader context of rising medical expenses associated with ACA coverage. Insurers have had to respond to a climate where more generous federal subsidies have expired, influencing members' decisions regarding continued enrollment.
Centene's medical loss ratio (MLR), an important indicator of the percentage of premiums spent on patient care, improved significantly to 79.2% compared to 90.6% from the prior year. The enhanced MLR can be attributed to the premium increases enacted for 2026 and a tapering medical trend, allowing the payer to reduce anticipated spending.
This MLR improvement was bolstered further by a favorable adjustment from a government program designed to provide financial support to insurers with higher-risk enrollees, amounting to approximately $180 million in net pre-tax favorability for the quarter.
Despite recent positive developments, Centene is bracing for further challenges ahead, particularly in its Medicaid business segment. Membership fell by over 700,000, limiting enrollment in this critical program to about 12.1 million people. These reductions resulted from various changes at the state level that altered eligibility criteria for Medicaid recipients. As states continue to reassess their Medicaid policies, additional membership declines are anticipated.
Both Medicaid and ACA segments face volatility as new work policies and program changes could directly affect enrollees. While the situation remains complex, Centene is committed to working with states to manage any disruptions to its membership.
In conjunction with its financial announcements, Centene has been actively restructuring its leadership. The company is expected to further streamline its workforce due to reduced membership numbers. Recently, Centene initiated buyout offers to its approximately 61,000 employees as part of its strategy to align with its operational needs moving forward.
In a notable transition, longtime board member Kenneth Burdick announced his retirement, resulting in Paul Diaz from Cressey & Company stepping in as a new addition to Centene's board. Such leadership changes reflect Centene's ongoing commitment to adapt in a challenging and evolving healthcare marketplace.